EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $2 | -60.0% | 394 | -58.4% | 0.00% | – |
| Q4 2023 | $5 | -70.6% | 948 | -11.0% | 0.00% | – |
| Q3 2023 | $17 | -19.0% | 1,065 | 0.0% | 0.00% | – |
| Q2 2023 | $21 | -83.7% | 1,065 | -76.6% | 0.00% | -100.0% |
| Q1 2023 | $129 | -5.1% | 4,557 | -2.3% | 0.00% | 0.0% |
| Q4 2022 | $136 | -99.9% | 4,664 | -9.6% | 0.00% | 0.0% |
| Q3 2022 | $136,000 | -42.4% | 5,159 | -2.8% | 0.00% | -50.0% |
| Q2 2022 | $236,000 | -9.9% | 5,306 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $262,000 | -54.4% | 5,296 | -53.0% | 0.00% | 0.0% |
| Q4 2021 | $574,000 | +74.5% | 11,272 | +91.1% | 0.00% | -33.3% |
| Q3 2021 | $329,000 | +28.0% | 5,900 | -1.6% | 0.00% | +50.0% |
| Q2 2021 | $257,000 | – | 5,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hudson Executive Capital LP | 1,323,794 | $79,534,000 | 3.54% |
| Park West Asset Management LLC | 1,171,880 | $70,406,000 | 2.96% |
| Matarin Capital Management, LLC | 170,008 | $10,214,000 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 140,014 | $8,412,000 | 0.82% |
| Capital Impact Advisors, LLC | 33,725 | $2,026,000 | 0.71% |
| U S GLOBAL INVESTORS INC | 18,800 | $1,130,000 | 0.51% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 187,989 | $11,294,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,442,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 18,751 | $1,127,000 | 0.21% |
| Foundry Partners, LLC | 70,357 | $4,227,000 | 0.16% |